
    
      A clinical evaluation to:

        -  Confirm that there are no adverse interactions when Ventricular Tachyarrhythmia (ICD),
           Heart Failure (HF) and Atrial Tachyarrhythmia (AT) therapies are combined

        -  Confirm Cardiac Resynchronization Therapy (CRT) and Ventricular Tachyarrhythmia (ICD)
           therapy is delivered in the presence of atrial therapies

        -  Demonstrate the safety and effectiveness of atrial therapies in a heart failure
           population
    
  